- Slow traction clouding GSK-Dr Reddy's expansive deal?
- GSK plans to divest old drugs except in emerging markets
- US Capitol Capsule: Time to 'go big' on cures innovation, lawmakers declare
- New Takeda moves signal emerging markets intent
COMMENT Other Informa Comment
- PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
- PROFILE: Antisense pioneer Stanley Crooke on injustice, the American dream, and letting go